Latest news and analysis in health.
Vertex's zimislecel stem cell therapy achieved insulin independence in 10 of 12 patients. FDA filing expected 2026. Here's what it means for 1.5M people.
Delegates in Geneva face a deadline to finalize the PABS annex to the WHO Pandemic Agreement. Here's what's at stake for global health equity in 2026.
Moderna and Merck's personalized mRNA cancer vaccine shows sustained 49% risk reduction in melanoma recurrence at five years, with Phase III results expected in 2026.
New research shows GLP-1 drugs like semaglutide may reverse biological aging markers, reduce cancer risk, and protect the brain — far beyond weight loss.
Complete 2026 comparison of Ozempic, Wegovy, Mounjaro, and Zepbound — pricing after the Trump deal, weight loss data, new oral pills, and Medicare coverage.
Candida auris infections have surged to 7,000+ US cases with 30-60% mortality rates. Here's why WHO calls this fungal pathogen a critical global threat.
After FDA rejection and a corporate rebrand, Resilient Pharmaceuticals bets $150 million on a new Phase 3 trial for MDMA-assisted PTSD therapy in 2026.
Oxford's R21 malaria vaccine rollout has now reached 25 African countries with 28 million doses administered in 2025. Here's what the early field data shows.
Vertex's zimislecel stem cell therapy achieved insulin independence in 10 of 12 trial patients and moves toward FDA submission as a functional diabetes cure.
BioNTech's individualized mRNA pancreatic cancer vaccine shows durable T-cell responses in half of Phase 1 patients as global Phase 2 trial expands.
Eli Lilly's retatrutide triple agonist achieves 28.7% weight loss in TRIUMPH-4 trial, matching bariatric surgery outcomes and reshaping obesity treatment.
Moderna's mRNA flu vaccine mRNA-1010 wins FDA review after initial rejection, with a decision date of August 5, 2026 for potential approval.
A CDC serosurvey of 150 bovine veterinarians found three with undetected H5N1 infections. Two had no known exposure to infected herds, suggesting wider spread than official counts.
Novo Nordisk's oral Wegovy received FDA approval in January 2026. Supply shortages have eased while government pricing deals and weight-regain data reshape the obesity drug market.
OpenAI says 40 million people use ChatGPT for health-related queries. ChatGPT Health can use medical records. Here's what that means and the risks.
Medicare open enrollment for 2026 runs October 15–December 7, 2025. Premiums drop, drug cap hits $2,100, and vaccines are free. What to know.
Ozempic and Wegovy use semaglutide; Mounjaro uses tirzepatide. In head-to-head trials, tirzepatide led to greater weight loss. Here's the comparison and what to discuss with your doctor.
Beacon Promotions Inc. recalls repackaged M&M's in 20 states. Packages lack required allergen labels for milk, soy, and peanuts; FDA classifies the recall as Class II.
